# Nuclide record nct04724369 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct04724369/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct04724369", "NCT04724369" ;
  schema:name "Open-Label Study of 18F-mFBG for Imaging Neuroblastoma"@en ;
  schema:description "A phase 3 trial of 18F-MFBG in neuroblastoma, run by Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC), active and no longer recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct04724369/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04724369> ;
  nuclide:status "active" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:phase "3" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:indications <https://nuclide.cc/indications/neuroblastoma/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet/> .
